Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OHI vs DOC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OHI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

OHI Overall Winner 6-Pillar Tally: OHI 3 – 3 DOC Matrix Metrics: OHI 6 – 4 DOC

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Healthpeak Properties, Inc. (DOC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas DOC carries 51.9/100 (HOLD) at $19.68 (142.7x Forward P/E, 15.7% operating margin).

  • Composite vs. Pillar Nuance: While DOC currently prints a higher short-term Unified Composite Score (51.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 15.7% operating margin) and revenue trajectory (-0.6% vs. +16.3% YoY).
  • Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile DOC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OHI vs DOC
OHI NYSE Head-to-Head Winner
Omega Healthcare Investors Inc.
Real Estate Investment Trusts
$46.91
-0.29% 1D
Market Cap $15.0B
TTM Revenue $1.26B
Forward P/E 22.6x
Beta / 30D Vol -0.04β · 29% Vol
Unified Composite Score
50.5 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 71.0 Mom 41.7
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 50
RSI-14: 49.6 · SMA20: $47.08 · SMA50: $46.44
DOC NYSE
Healthpeak Properties, Inc.
Real Estate Investment Trusts
$19.68
-1.53% 1D
Market Cap $14.6B
TTM Revenue $3.06B
Forward P/E 142.7x
Beta / 30D Vol 0.37β · 28% Vol
Unified Composite Score
51.9 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.5 · SMA20: $19.58 · SMA50: $19.66

6-Pillar Scorecard Institutional Category Breakdown (OHI 3 – 3 DOC)

Columns: Metric · OHI · DOC
1. Valuation Multiples OHI
Forward P/E 22.6x 142.7x
Trailing P/E 19.0x 37.3x
PEG Ratio 11.99x 4.08x
EV / Revenue 14.9x 4.8x
2. Growth & Scale DOC
Revenue Growth (YoY) -0.6% +16.3%
Earnings Growth (YoY) -55.4% +68.2%
TTM Revenue (USD) $1.26B $3.06B
Market Cap $15.0B $14.6B
3. Profitability & Quality OHI
Gross Margin 95.8% 56.1%
Operating Margin 62.6% 15.7%
Net Profit Margin 60.5% 12.3%
Return on Equity (ROE) 14.5% 4.4%
4. Balance Sheet & Cash Flow DOC
Cash Generation (TTM) $855M $1.59B EBITDA
Cash Flow Margin 67.9% 51.8% EBITDA Mgn
Net Cash / Leverage $3.83B Net Debt (0.73x D/E) $11.41 Book/Sh · 4.4% ROE
Dividend Yield 5.61% 5.99%
5. Options & Positioning OHI
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 26.9% (65th %ile) 20.7% (25th %ile)
Put/Call OI Skew 0.71x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat DOC
OpEx & R&D Intensity 33.2% of Rev ($418M) 40.4% of Rev ($1.24B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OHI (6) vs DOC (4)
Institutional Metric OHI DOC Criterion Row Edge
Market Capitalization
Scale
$15.0B $14.6B Larger Scale OHI
Trailing P/E Ratio
Valuation
19.0x 37.3x Lower Multiple OHI
Forward P/E Ratio
Valuation
22.6x 142.7x Lower Multiple OHI
Revenue Growth (YoY)
Growth
-0.6% +16.3% Higher Growth DOC
Operating Margin (TTM)
Profitability
62.6% 15.7% Higher Margin OHI
Net Profit Margin
Profitability
60.5% 12.3% Higher Margin OHI
Return on Equity (ROE)
Capital Efficiency
14.5% 4.4% Higher ROE OHI
52-Week Range Position
Momentum
46% ($42–$52) 55% ($16–$23) Stronger Trend DOC
Beta / 30D Volatility
Risk Regime
-0.04β · 29% Vol 0.37β · 28% Vol Lower Realized Risk DOC
Unified Institutional Score
Composite Signal
50.5 / 100 (HOLD) 51.9 / 100 (HOLD) Higher Composite DOC
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $3.06B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.8% 56.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
11.99x PEG · 14.9x EV/Rev 4.08x PEG · 4.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$855M ($3.83B Net Debt (0.73x D/E)) $1.59B EBITDA ($11.41 Book/Sh · 4.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DOC +0.87 pp
OHI: +2.79% · DOC: +3.66%
3M Horizon OHI +4.76 pp
OHI: +1.02% · DOC: -3.74%
6M Horizon DOC +3.86 pp
OHI: -2.91% · DOC: +0.95%
1Y Horizon DOC +4.39 pp
OHI: +7.97% · DOC: +12.36%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OHI vs DOC. Trailing 12-month operating profitability (OHI 62.6% vs DOC 15.7%) and valuation multiples (OHI 22.6x vs DOC 142.7x Forward P/E) are benchmarked directly in Pillar 4 below.

OHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.26B
Gross Margin95.8%
Op. Margin62.6%
ROE / Fwd P/E14.5% · 22.6x
DOC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.06B
Gross Margin56.1%
Op. Margin15.7%
ROE / Fwd P/E4.4% · 142.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OHI CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 26.9%
IV Percentile 65th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact OHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DOC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 20.7%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DOC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment 33.2% of Rev ($418M)
90D Engineering Disclosures 0 Published
DOC Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $14.6B market capitalization and 15.7% operating margin.
OpEx & R&D Reinvestment 40.4% of Rev ($1.24B)
90D Engineering Disclosures 0 Published

Investor FAQ OHI vs DOC Key Questions & Quantitative Answers

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Healthpeak Properties, Inc. (DOC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas DOC carries 51.9/100 (HOLD) at $19.68 (142.7x Forward P/E, 15.7% operating margin). Composite vs. Pillar Nuance: While DOC currently prints a higher short-term Unified Composite Score (51.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 15.7% operating margin) and revenue trajectory (-0.6% vs. +16.3% YoY). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile DOC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DOC leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with DOC at +16.3% YoY revenue growth and +68.2% YoY earnings growth on $3.06B TTM revenue (56.1% gross margin, 15.7% operating margin). On trailing 12-month operating scale, OHI generates $1.26B in USD-normalized revenue versus $3.06B for DOC. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 40.4% of Rev ($1.24B) (0 disclosures) for DOC.

OHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas DOC trades at 142.7x Forward P/E, 37.3x Trailing P/E, 4.08x PEG, and 4.8x EV/Revenue (51.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus DOC (4.4% ROE) capital efficiency.

In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, DOC carries 20.7% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.